Ignite Creation Date:
2024-05-06 @ 8:24 AM
Last Modification Date:
2024-10-26 @ 12:00 PM
Study NCT ID:
NCT02734953
Status:
COMPLETED
Last Update Posted:
2018-09-24
First Post:
2016-03-26
Brief Title:
Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH
Sponsor:
Allegheny Singer Research Institute also known as Allegheny Health Network Research Institute
Organization:
Allegheny Singer Research Institute also known as Allegheny Health Network Research Institute
Study Overview
Official Title:
Effects of iNO on Invasively Derived Pulmonary Vascular Parameters in Patients With Pulmonary Arterial Hypertension
Status:
COMPLETED
Status Verified Date:
2018-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Pulmonary hypertension is characterized by an increase in the pressures in the blood supply to the lungs greater than a mean pressure of 25mmHg and a concomitant increase in overall pulmonary vascular resistance PVR In patients who have remodeling of their pulmonary vasculature PVR will increase with exercise instead of decreasing as it would in normal patients Based on published evidence the investigators intend to investigate the effects of inhaled nitric oxide iNO on patients undergoing standard exercise techniques who have separately and previously had an implanted pulmonary artery monitoring device CardioMems by St Jude Medical Inc placed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None